Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 13Unknown 7Not yet recruiting 3Terminated 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Hypnosis × Clear all
NCT04694885 2025-07-09

QoLMa

University Hospital, Basel, Switzerland

Phase NA Recruiting
62 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression

NCT05197972 2025-04-16

COHEC2

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
296 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡